AEE788 : A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity Peter Traxler, Peter R. Allegrini,et al. Cancer Res 2004;64:4931-4941
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells Eva Juengel, Johanna Engler,et al. BMC Cancer 2009;9:161
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma1 Daniela Meco,Tiziana Servidei,et al. Translational Oncology 2010;3:326–335
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.